2-({6-[(3R)-3-amino-3-methylpiperidine-1-yl]-1,3-dimethyl-2,4-dioxo-1,2,3,4-tetrahydro-5H-pyrrolo[3,2-d]pyrimidine-5-yl}methyl)-4-fluorobenzonitrile (DSR-12727): A potent, orally active dipeptidyl peptidase IV inhibitor without mechanism-based inactivation of CYP3A
作者:Yukihiro Nishio、Hidenori Kimura、Naoyuki Sawada、Eiji Sugaru、Masakuni Horiguchi、Michiko Ono、Yudai Furuta、Mutsuko Sakai、Yumi Masui、Misato Otani、Takahiko Hashizuka、Yayoi Honda、Jiro Deguchi、Tsutomu Nakagawa、Hiroyuki Nakahira
DOI:10.1016/j.bmc.2011.07.042
日期:2011.9
Wereport on the identification of 2-(6-[(3R)-3-amino-3-methylpiperidine-1-yl]-1,3-dimethyl-2,4-dioxo-1,2,3,4- tetrahydro-5H-pyrrolo[3,2-d] pyrimidine-5-yl}methyl)-4-fluorobenzonitrile (DSR-12727) (7a) as a potent and orally active DPP-4 inhibitor without mechanism-based inactivation of CYP3A. Compound 7a showed good DPP-4 inhibitory activity (IC50 = 1.1 nM), excellent selectivity against related peptidases and other off-targets, good pharmacokinetic and pharmacodynamic profile, great in vivo efficacy in Zucker-fatty rat, and no safety concerns both in vitro and in vivo. (C) 2011 Elsevier Ltd. All rights reserved.